Cargando…
Early Relapse after Autologous Hematopoietic Cell Transplantation remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time
Duration of initial disease response remains a strong prognostic factor in multiple myeloma (MM) particularly for upfront autologous hematopoietic cell transplant (AHCT) recipients. We hypothesized that new drug classes and combinations employed prior to AHCT as well as after post-AHCT relapse may h...
Autores principales: | Kumar, Shaji K, Dispenzieri, Angela, Fraser, Raphael, Mingwei, Fei, Akpek, Gorgun, Cornell, Robert, Kharfan-Dabaja, Mohamed, Freytes, Cesar, Hashmi, Shahrukh, Hildebrandt, Gerhard, Holmberg, Leona, Kyle, Robert, Lazarus, Hillard, Lee, Cindy, Mikhael, Joseph, Nishihori, Taiga, Tay, Jason, Usmani, Saad, Vesole, David, Vij, Ravi, Wirk, Baldeep, Krishnan, Amrita, Gasparetto, Cristina, Mark, Tomer, Nieto, Yago, Hari, Parameswaran, D’Souza, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871538/ https://www.ncbi.nlm.nih.gov/pubmed/29263438 http://dx.doi.org/10.1038/leu.2017.331 |
Ejemplares similares
-
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: A Center for International Blood and Marrow Transplant Research Analysis
por: Mahindra, Anuj, et al.
Publicado: (2017) -
A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease
por: Rafei, Hind, et al.
Publicado: (2017) -
Hematopoietic Cell Transplantation for Primary Plasma Cell Leukemia: Results from the Center for International Blood and Marrow Transplant Research
por: Mahindra, Anuj, et al.
Publicado: (2011) -
Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome
por: Goyal, Sagun D., et al.
Publicado: (2015) -
Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation
por: Cheng, Yee Chung, et al.
Publicado: (2017)